|
⚲
|
| Keyboard |
| Chris Ehrlich | |
|---|---|
| Firm | |
| Address | 201 Haskins Way, Suite 230 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| CERO Therapeutics Holdings Inc | 021-545301 | Executive Officer | 5.0 M of 8.0 M |
||
| CERO Therapeutics Holdings Inc | 021-525940 | Executive Officer | 1.2 M of 1.2 M |
||
| Carbylan Biosurgery Inc | 021-189403 | Director | 6.0 M of 13.2 M |
||
| Invuity Inc | 021-179677 | Director | 25.0 M of 25.0 M |
||
| Satori Pharmaceuticals Inc | 021-173852 | Director | 15.0 M of 19.2 M |
||
| Invuity Inc | 021-171349 | Director | 2.0 M of 2.0 M |
||
| Invuity Inc | 021-144326 | Director | 13.2 M of 16.0 M |
||
| Quatrx Pharmaceuticals Co | 021-39151 | Director | 14.0 M of 37.1 M |
||
| Biomimetic Therapeutics Inc | 021-55779 | Director | 2.9 M of 2.9 M |
||